Search the webpage

Created by Leona Damalakienė on   September 12, 2019   in category: News

ERM2019 attendees!

Experimentica’s poster evidently illustrating the effectivity of Aflibercept, administered systemically,  protection against the development of neovascular lesions - will be presented in today’s afternoon poster session.

And for the first time - a demonstration of convolutional neural network trained to recognize and quantify choroidal neovascularization lesion using Aiforia® Cloud.

 

LATEST NEWS

Advances in preclinical in vivo imaging: OCT-Angiography of the rat retina

News
OCT-Angiography (OCT-A) scan of the adult rat retina. Already routinely used in the clinical setting, this non-invasive imaging technique to ... Read More

Experimentica at Bio Partnering event in Shanghai 2019

News
Experimentica Ltd. participates at Bio Partnering APAC conference in Shanghai, China, on September 24-25, 2019 ... Read More

Visit our poster in 17th European Congress of Toxicologic Pathology

News
Experimentica's partner Aiforia Technologies Oy will present joint poster dedicated for illustration of the effectivity of Aflibercept, administered systemically and ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!